Technology | June 26, 2006

The first FDA-cleared chest X-ray CAD system to assist in detecting early-stage lung cancer, RapidScreen is designed to quickly identify solitary pulmonary nodules between 9 and 30 mm and other suspicious nodules on the original standard AP/PA chest X-ray, providing a virtual second pair of eyes for the radiologist. The system offers film and filmless solutions as well as an upgrade path for those seeking to evolve to filmless in the future.


Related Content

News | Radiology Business

January 18, 2023 — Addressing the growing demand for medical imaging and a shortage of radiologists, Bayer announced the ...

Time January 18, 2023
arrow
News | Artificial Intelligence

December 14, 2022 — Dallas, TX-based MedCognetics, Inc. announced it has received U.S Food and Drug Administration (FDA) ...

Time December 14, 2022
arrow
News | Breast Imaging

November 25, 2022 — Hologic, Inc. will exhibit its extensive portfolio of breast and skeletal health products at the ...

Time November 25, 2022
arrow
News | Digital Pathology

September 13, 2022 — Deciphex, a Dublin, Ireland-based provider of digital pathology software and services, has ...

Time September 13, 2022
arrow
News | Stroke

December 1, 2020 – Medical imaging artificial intelligence (AI) vendor Avicenna.AI today announced its FDA-cleared CINA ...

Time December 01, 2020
arrow
Feature | Artificial Intelligence | Sanjay Parekh, Ph.D. 

February 7, 2020 – At the 2019 Radiological Society of North America (RSNA) meeting in December, there was a record ...

Time February 07, 2020
arrow
News | Computer-Aided Detection Software

January 22, 2020 — The U.S. Food and Drug Administration (FDA) has issued a final order to reclassify medical image ...

Time January 22, 2020
arrow
News | Artificial Intelligence

October 31, 2019 — Zebra Medical Vision, a deep learning medical imaging analytics company, announced this week a ...

Time October 31, 2019
arrow
Feature | Breast Imaging

October 28, 2019 — Artificial intelligence (AI) helps improve the efficiency and accuracy of an advanced imaging ...

Time October 28, 2019
arrow
News | Artificial Intelligence

Artificial intelligence (AI) software developer Enlitic Inc. announced it has signed a strategic partnership with Select HealthCare Solutions, a developer, owner and operator of cancer centers across the U.S. As part of the agreement, Enlitic will receive access to Select Healthcare’s high-quality, anonymized patient data –– data that will further tune Enlitic’s predictive models for early cancer detection. In turn, Select HealthCare will receive access to Enlitic’s AI software technology and will directly contribute to the development of future Enlitic products in radiology, oncology and pathology.

Time October 24, 2019
arrow
Subscribe Now